Clinical trial Recruiting at 1 site Observational Ages 21 and up

Creating guidelines for prostate cancer care using expert opinions

Official title: Key Elements for Standardized Reporting in Prostate Cancer Management: An Expert Delphi Consensus Study

Run by M.D. Anderson Cancer Center · NCT05054413 · Data updated 2026-11-12

This study is trying to create clear guidelines for prostate cancer care by gathering opinions from experts to help doctors provide better and more consistent treatment for patients.

Quick facts

Study typeObservational
Ages21 Years and up
SexAll
Enrollment10 (estimated)
SponsorM.D. Anderson Cancer Center
Academic / other
Drugs / interventionsRadiation
Locations1 site (Houston, Texas)
StatusRecruiting
StartedApril 15, 2021
Main results expectedAugust 1, 2030
Study endsAugust 1, 2030
Registry record updatedMay 26, 2026
Trial IDNCT05054413 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are board-certified medical providers actively treating prostate cancer patients.

Probably not a fit

Patients who are not medical providers or those who do not treat prostate cancer will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish consensus guidelines for key clinical elements in prostate cancer care through a remote Delphi method. A panel of certified experts in relevant fields will participate in multiple rounds of questionnaires to identify essential data elements for standardized reporting in electronic health records. The goal is to enhance the management of prostate cancer patients from diagnosis through survivorship by ensuring consistency in the information recorded. The study emphasizes the importance of expert input in developing these guidelines to improve patient care.

Why it matters

Potential benefit: If successful, this study could lead to improved standardization in prostate cancer care, enhancing patient management and outcomes.

How similar studies have gone: While similar consensus-building approaches have been utilized in other areas of cancer care, this specific application using the Delphi method for prostate cancer is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 21 and above
* Board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology
* Maintenance of an active practice that includes prostate cancer patients
* English speaking

Exclusion Criteria:

* Medical providers that are not board certified in the professions and/or those who do not treat prostate cancer
* Prisoners, children, and adults unable to consent to participation will also be excluded
* No exclusions were made based on sex, age, racial/ethnic background, or pregnancy status

Where it's running

  • M D Anderson Cancer Center
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.